Paper Details
- Home
- Paper Details
Gemifloxacin: effects of sub-inhibitory concentrations on various factors affecting bacterial virulence.
Author: BovioC, BragaP C, CuliciM, Dal SassoM
Original Abstract of the Article :
This study investigated the ability of sub-MICs of gemifloxacin to interfere with the bacterial virulence parameters of adhesiveness, haemagglutination, hydrophobicity and motility, as well as their interactions with host neutrophilic defences such as phagocytosis, killing and respiratory bursts. Th...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/s0924-8579(02)00391-6
データ提供:米国国立医学図書館(NLM)
Sub-Inhibitory Gemifloxacin: A Silent Warrior Against Bacterial Virulence
The field of [antimicrobial resistance] is a battleground where bacteria are constantly evolving, like a desert that shifts its sands with every storm. This research investigates the subtle effects of [gemifloxacin] at sub-inhibitory concentrations, exploring the possibility of a silent warrior against the forces of bacterial virulence. The researchers used a variety of techniques to examine how [gemifloxacin] interacts with bacterial virulence factors, like [adhessiveness, haemagglutination, hydrophobicity, and motility], as well as the body's own immune response. The results indicate that [gemifloxacin] can effectively disrupt bacterial virulence, even at concentrations below what is needed to directly kill the bacteria.
A Silent Warrior's Tactics: Subduing the Enemy From Within
This study reveals that even at low levels, [gemifloxacin] can significantly impair bacterial virulence, like a desert wind subtly eroding a sand dune. This finding is particularly noteworthy because it suggests that [gemifloxacin] may be able to extend its antimicrobial effects beyond the initial period of treatment, akin to a fortress that maintains its defenses even after the enemy has been repelled.
A Beacon in the Desert: Hope for a Lasting Battle
This research offers a glimmer of hope in the ongoing battle against antibiotic resistance. It suggests that we can use [gemifloxacin] as a strategy to weaken bacterial virulence, even before they reach critical mass. It's a step towards a more sustainable approach to combating bacterial infections, like carefully managing a desert oasis to ensure its longevity.
Dr.Camel's Conclusion
The desert of antimicrobial resistance is a challenging landscape, but this research demonstrates the power of subtle tactics. By understanding the nuances of [gemifloxacin]'s effects, we can potentially develop new strategies to outsmart our bacterial foes.
Date :
- Date Completed 2003-12-05
- Date Revised 2019-09-22
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.